HAI Pathogens and Antimicrobial Resistance Report, 2018-2021

Adult Data Tables

Print
PAGE 15 of 19

‹View Table of Contents

Related Pages

Table 14. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1, by Location Type, Adults, 2018-2021

Table 14. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type, Adults, 2018-2021
Hospital ICUs Hospital Wards Oncology Units LTACHs IRFs
  Pathogen, Antimicrobial Phenotype # Reported % Tested %R # Reported % Tested %R # Reported % Tested %R # Reported % Tested %R # Reported % Tested %R
Urgent Threats Acinetobacter spp. 156 234 13 120 27
Carbapenem-NS 74.4 44.8 78.6 51.1 . . 89.2 83.2 . .
Select Enterobacterales2 22,372 25,145 1,354 4,107 3,052
Carbapenem-resistant (CRE) 74.7 1.8 75.4 2.2 76.5 2.0 84.0 8.4 75.8 1.4
Serious Threats Select Enterobacterales3 19,955 22,725 1,211 3,631 2,728
Extended-spectrum cephalosporin-NS 85.8 21.5 85.9 24.4 86.5 25.7 92.2 41.6 87.7 15.6
Enterobacter spp. 1,930 2,042 122 397 252
Cefepime-NS 80.0 13.3 75.3 13.0 81.1 13.1 85.1 27.2 78.6 11.1
Enterococcus faecalis 5,273 4,796 317 572 355
Vancomycin-resistant (VRE) 89.3 2.8 89.2 5.5 91.8 5.8 89.3 24.5 93.2 5.1
Enterococcus faecium 1,303 1,242 101 500 57
Vancomycin-resistant (VRE) 92.7 76.5 92.4 79.2 94.1 83.2 97.6 88.9 94.7 72.2
Pseudomonas aeruginosa 5,701 7,283 424 2,034 850
Multidrug-resistant (MDR) 95.7 8.7 95.2 10.6 93.2 9.9 99.1 20.8 95.9 6.7
Staphylococcus aureus 634 999 61 107 89
Meth/ox/cefox – resistant (MRSA) 91.5 39.8 91.4 53.2 93.4 52.6 89.7 81.3 93.3 63.9

Note: Percent resistance is not calculated when the number of tested isolates is < 20. Refer to Technical Resources for more information about phenotype definitions, acronyms, and terms used in this table.

Footnotes:

  1. As classified by CDC’s 2022 Special Report: COVID-19 U.S. Impact on Antimicrobial Resistance [PDF – 10.7 MB]
  2. Consists of E. coli, Klebsiella oxytoca, Klebsiella pneumoniae, Klebsiella aerogenes, and Enterobacter spp.
  3. Consists of E. coli, Klebsiella oxytoca, and Klebsiella pneumoniae.

HAI Pathogens and Antimicrobial Resistance Report Data Tables 2018-2021 - Adult HAIs

  1. HAI Pathogens and Antimicrobial Resistance Report 2018-2021 Data Tables - Adult HAIs
  2. Table 1. Facilities Reporting at Least 1 HAI Pathogen to NHSN
  3. Table 2. Frequency of Pathogens and HAI Events Reported to NHSN, by HAI Type
  4. Table 3. The Top 15 HAI Pathogens Reported to NHSN
  5. Table 4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type
  6. Table 5. The Top 15 CAUTI Pathogens Reported to NHSN, by Location Type
  7. Table 6. The Top 15 PVAP Pathogens Reported to NHSN, by Facility Type
  8. Table 7. Frequency of SSI Pathogens, by Surgical Category and SSI Type
  9. Table 8. The Top 15 SSI Pathogens Reported to NHSN, by SSI Type
  10. Table 9. The Top 15 SSI Pathogens Reported to NHSN Following Surgery Types with High Pathogen Volume
  11. Table 10. The Top 15 SSI Pathogens Reported to NHSN Following Select Surgery Types with Low Pathogen Volume
  12. Table 11. Percent of HAI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1, by HAI Type
  13. Table 12. Percent of CLABSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  14. Table 13. Percent of CLABSI Pathogens Reported From Oncology Units That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Threats, by Mucosal Barrier Injury (MBI) Status
  15. ›Table 14. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  16. Table 15. Percent of PVAP Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Facility Type
  17. Table 16. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Surgical Categories with High Pathogen Volume
  18. Table 17. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Select Surgical Categories with Low Pathogen Volume
  19. Table 18. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by SSI Type